AURA

Aura Biosciences, Inc.

• TipRanks·03/30 20:50

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Aura Biosciences Inc (AURA) and Kezar Life Sciences (KZR)

• TipRanks·03/30 18:15

  Aura Biosciences: Strong Cash Runway and Accelerating bel-sar Clinical Momentum Support Buy Rating

• Dow Jones·03/30 17:53

  Aura Biosciences Price Target Maintained With a $22.00/Share by HC Wainwright & Co.

• Benzinga·03/30 17:44

  HC Wainwright & Co. Reiterates Buy on Aura Biosciences, Maintains $22 Price Target

• TipRanks·03/30 16:30

  Analysts Are Bullish on Top Healthcare Stocks: Aura Biosciences Inc (AURA), Bicara Therapeutics Inc. (BCAX)

• TipRanks·03/30 12:10

  Aura Biosciences Reports 2025 Results, Advances Bel-Sar Pipeline

• Reuters·03/30 11:38

  Aura Biosciences presentation outlines bel-sar phase 3 program in early choroidal melanoma

• Benzinga·03/30 11:17

  Aura Biosciences Q4 EPS $(0.37) Beats $(0.45) Estimate

• Seeking Alpha·03/30 11:14

  Aura Biosciences GAAP EPS of -$1.76 beats by $0.19

• Reuters·03/30 11:09

  Aura Biosciences 2025 net loss widens as R&D costs rise

• Reuters·03/30 11:06

  Aura Biosciences FY25 net loss widens 22.2% to $106M; R&D expense rises to $90M

• Dow Jones·03/30 11:05

  *Aura Biosciences 4Q Loss $25.6M >AURA

• Dow Jones·03/30 11:01

  *Aura Biosciences: Runway To Fund Operaions Into 1Q 2027 >AURA

• Reuters·03/30 11:00

  BRIEF-Aura Biosciences FY Operating Expenses USD 112.791 Million

• Reuters·03/30 11:00

  AURA BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS